- Home
- JFU vs MIRA Comparison
JFU vs MIRA Comparison
Compare JFU & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JFU | MIRA |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.5M | 50.3M |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | JFU | MIRA |
|---|---|---|
| Price | $4.55 | $1.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.8K | ★ 157.6K |
| Earning Date | 12-09-2022 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3110.57 | N/A |
| EPS | ★ 3.04 | N/A |
| Revenue | ★ $44,573,690.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.49 | ★ N/A |
| Revenue Growth | ★ 8.19 | N/A |
| 52 Week Low | $1.01 | $0.73 |
| 52 Week High | $9.48 | $2.45 |
Technical Indicators
Market Signals| Indicator | JFU | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 35.10 |
| Support Level | $4.15 | $1.17 |
| Resistance Level | $4.88 | $1.25 |
| Average True Range (ATR) | 0.46 | 0.07 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 25.82 | 18.84 |
Price Performance
Historical ComparisonAbout JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.